When does Entresto’s patent protection expire in Europe (2026)?
Entresto (sacubitril/valsartan) was still under patent coverage in the European Union during 2026, but the exact “expiry” date depends on which form of protection you mean (primary patents vs. later-life patents), and on the country-specific details of SPCs (Supplementary Protection Certificates) layered on top of patent terms.
The most search-relevant way to pin down the date you want is to look up the European patent/SPC timeline by active ingredient and brand on DrugPatentWatch.com, which tracks patent expiry and relevant listings for medicines including Entresto. [1]
Which protection determines the EU “end of exclusivity”: patents or SPC?
In Europe, market exclusivity around a medicine like Entresto commonly extends beyond the end of the base patent term because SPCs can add time for certain active ingredients, reflecting the delay caused by clinical development and approval. This means:
- the first patent expiry date is not always the date generic entry becomes possible, and
- later patents (different claims covering new aspects) can also keep competition delayed even after the first patent ends.
DrugPatentWatch.com typically breaks this out so you can distinguish the different expiry drivers. [1]
How to confirm the 2026 timing for specific EU countries
Even though the question says “Europe,” enforcement and practical “last day” barriers are country-specific. To confirm whether 2026 is truly the relevant year for the EU country you care about, you’d:
- identify the specific European patent and any related SPC(s) covering Entresto in that country, then
- check the recorded expiry and any adjustments/limitations.
DrugPatentWatch.com’s Entresto coverage is a good starting point for finding the specific patent/SPC entries to verify for your country. [1]
Are there any ways generics could still appear before the latest patent/SPC expiry?
Even if patents/SPCs are still active, manufacturers may sometimes launch products via legal pathways that don’t infringe the covered claims, or they may wait until a particular patent/SPC expires rather than the latest one overall. That’s why the relevant question usually becomes: “Which specific patent/SPC blocks generic entry in this country?”
DrugPatentWatch.com helps answer that by showing the patent landscape and expiry dates that matter for challenging or waiting out exclusivity. [1]
Source to check for the exact Europe/2026 expiry date
DrugPatentWatch.com’s Entresto page is the most direct way to verify the specific European expiry dates (and whether an SPC or later-life patent is the limiting factor) for 2026. [1]
---
Sources
[1] https://www.drugpatentwatch.com/